Next Article in Journal
Next Article in Special Issue
Previous Article in Journal
Previous Article in Special Issue
Viruses 2012, 4(8), 1212-1234; doi:10.3390/v4081212
Article

Persistence versus Reversion of 3TC Resistance in HIV-1 Determine the Rate of Emergence of NVP Resistance

1,2,* , 3
, 3
 and 1
Received: 11 July 2012; in revised form: 3 August 2012 / Accepted: 6 August 2012 / Published: 7 August 2012
(This article belongs to the Special Issue HIV Dynamics and Evolution)
View Full-Text   |   Download PDF [390 KB, uploaded 7 August 2012]
Abstract: When HIV-1 is exposed to lamivudine (3TC) at inhibitory concentrations, resistant variants carrying the reverse transcriptase (RT) substitution M184V emerge rapidly. This substitution confers high-level 3TC resistance and increased RT fidelity. We established a novel in vitro system to study the effect of starting nevirapine (NVP) in 3TC-resistant/NNRTI-naïve clinical isolates, and the impact of maintaining versus dropping 3TC pressure in this setting. Because M184V mutant HIV-1 seems hypersusceptible to adefovir (ADV), we also tested the effect of ADV pressure on the same isolates. We draw four conclusions from our experiments simulating combination therapy in vitro. (1) The presence of low-dose (1 μM) 3TC prevented reversal to wild-type from an M184V mutant background. (2) Adding low-dose 3TC in the presence of NVP delayed the selection of NVP-associated mutations. (3) The presence of ADV, in addition to NVP, led to more rapid reversal to wild-type at position 184 than NVP alone. (4) ADV plus NVP selected for greater numbers of mutations than NVP alone. Inference about the “selection of mutation” is based on two statistical models, one at the viral level, more telling, and the other at the level of predominance of mutation within a population. Multidrug pressure experiments lend understanding to mechanisms of HIV resistance as they bear upon new treatment strategies.
Keywords: HIV-1; lamivudine; nevirapine; adefovir; resistance; selection; serial passage HIV-1; lamivudine; nevirapine; adefovir; resistance; selection; serial passage
This is an open access article distributed under the Creative Commons Attribution License which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Export to BibTeX |
EndNote


MDPI and ACS Style

Rath, B.A.; Olshen, R.A.; Halpern, J.; Merigan, T.C. Persistence versus Reversion of 3TC Resistance in HIV-1 Determine the Rate of Emergence of NVP Resistance. Viruses 2012, 4, 1212-1234.

AMA Style

Rath BA, Olshen RA, Halpern J, Merigan TC. Persistence versus Reversion of 3TC Resistance in HIV-1 Determine the Rate of Emergence of NVP Resistance. Viruses. 2012; 4(8):1212-1234.

Chicago/Turabian Style

Rath, Barbara A.; Olshen, Richard A.; Halpern, Jerry; Merigan, Thomas C. 2012. "Persistence versus Reversion of 3TC Resistance in HIV-1 Determine the Rate of Emergence of NVP Resistance." Viruses 4, no. 8: 1212-1234.


Viruses EISSN 1999-4915 Published by MDPI AG, Basel, Switzerland RSS E-Mail Table of Contents Alert